Phase 1/2a Study on Allogeneic Osteoblastic Cells Implantation in Delayed-Union Fractures

NCT02020590 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Long Bone Delayed-Union Fracture

Interventions

DRUG: ALLOB® implantation

Sponsor

Bone Therapeutics S.A